Chorea Minor Associated with Anti-Neurochondrin Autoantibodies

Introduction Chorea minor is characterized by irregular, rapid, and chaotic movements, primarily affecting the hands, feet, and face. Autoimmune chorea minor, the most common form of acquired childhood chorea, is frequently triggered by antineuronal antibodies emerging afterAβ-hemolytic streptococcal infections,1,2 but other immunological abnormalities have also been reported.3 Recently, antibodies against neurochondrin, an intracellularneuronal targetantigenalsoexpressed instriatum,were newly discovered and detected in three adults with cerebellar degeneration.4 We report a 6-year-old girl who presented with choreatiform movements predominantly of the right arm and face (►Video 1, part I). Diagnostic workup revealed distinctly positive anti-neurochondrin antibodies in the patient’s serum4 (►Fig. 1A, B). Intravenous immunoglobulin (IVIG) treatment substantially improved the patient’s clinical symptoms (►Video 1, part II), and anti-neurochondrin antibody titers became negative. After 12 weeks of cessation of IVIG treatment clinical symptoms and the autoantibodies reappeared (►Video 1, part III). IVIG treatment was restarted, and the girl’s chorea improved again, while anti-neurochondrin autoantibodies ceased to exist (►Video 1, part IV). These observations suggest that anti-neurochondrin autoantibody determination may be meaningful in children with chorea minor.

[1]  L. Schöls,et al.  Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[2]  Francisco Cardoso Autoimmune choreas , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  J. Matsumoto,et al.  Autoimmune chorea in adults , 2013, Neurology.

[4]  J. Wilmshurst,et al.  An update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventions , 2010, Therapeutic advances in neurological disorders.